Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.

MLA

Moreau-Marquis, Sophie, et al. “Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas Aeruginosa Biofilms on Cystic Fibrosis Cells.” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 3, Sept. 2009, pp. 305–13. EBSCOhost, https://doi.org/10.1165/rcmb.2008-0299OC.

APA

Moreau-Marquis, S., O’Toole, G. A., & Stanton, B. A. (2009). Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. American Journal of Respiratory Cell and Molecular Biology, 41(3), 305–313. https://doi.org/10.1165/rcmb.2008-0299OC

Chicago

Moreau-Marquis, Sophie, George A O’Toole, and Bruce A Stanton. 2009. “Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas Aeruginosa Biofilms on Cystic Fibrosis Cells.” American Journal of Respiratory Cell and Molecular Biology 41 (3): 305–13. doi:10.1165/rcmb.2008-0299OC.